多巴胺受体自身抗体在传染病后的信号传递区分了运动与神经精神疾病之间的差异
Chandra M Menendez1, Jonathan Zuccolo1, Susan E Swedo2
1Department of Microbiology and Immunology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
JCI insight
|September 26, 2024
概括
针对多巴胺受体的自身抗体与A组链球菌感染有关. 多巴胺D1受体 (D1R) 和D2受体 (D2R) 自体抗体活性的差异可以区分神经精神疾病和运动障碍.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 与感染相关的神经精神疾病,如A组链球菌 (GAS),仍然是全球卫生挑战.
- 向多巴胺基神经元的自身抗体 (AAbs) 和多巴胺D2受体 (D2R) 信号都与此有关,但多巴胺D1受体 (D1R) 的AAb影响不太清楚.
- 气体感染可能会引发自身免疫反应,影响基底性,该区域对运动控制和行为至关重要.
研究的目的:
- 调查AAbs针对多巴胺D1受体 (D1R) 在GAS相关的神经精神疾病中的作用.
- 为了区分运动障碍背后的机制与GAS后续中的神经精神综合征.
- 探索D1R AAb信号通路及其作为诊断和治疗点的潜力.
主要方法:
- 在患者样本中分析D1R和D2RAAb标位,信号活性和免疫活性.
- 利用患者衍生的血清AAbs和单克隆抗体 (mAbs) 来研究D1R信号.
- 评估由AAbs和多巴胺影响的G蛋白和β-阿雷斯介导的信号通路.
主要成果:
- 在D1R和D2RAAb标位和信号传递中,不同的模式将神经精神综合征与运动障碍区分开来.
- 来自患者的AAbs和mAbs通过D1R诱导G蛋白和β-arrestin转导的信号.
- AAbs和mAbs可以增强多巴胺介导的D1R信号机制.
结论:
- 通过AAb介导的D1R信号传递是GAS感染后神经精神病学后果病变的潜在贡献者.
- 在D1R和D2R AAb概况的差异可以作为生物标志物来区分神经精神病和运动障碍.
- 针对AAb介导的D1R信号提供了与GAS相关的自身免疫疾病的新诊断和治疗途径.
相关概念视频
Parkinson's Disease: Overview
495
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
495
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Parkinson's Disease: Treatment
235
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
235
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
513
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
513
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K


